University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.


  1. Home


  2. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.


  3. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.

rakerr2

Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ. 2004 Oct 23;329(7472):972-5. Review.

Upcoming Events

Full Calendar

News Categories